proglycem

Generic: diazoxide

Labeler: teva pharmaceuticals usa, inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name proglycem
Generic Name diazoxide
Labeler teva pharmaceuticals usa, inc.
Dosage Form SUSPENSION
Routes
ORAL
Active Ingredients

diazoxide 50 mg/mL

Manufacturer
Teva Pharmaceuticals USA, Inc.

Identifiers & Regulatory

Product NDC 0575-6200
Product ID 0575-6200_451aa56d-e2e5-402f-843a-cddb5b3d37dd
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA017453
Listing Expiration 2026-12-31
Marketing Start 1990-09-30

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 05756200
Hyphenated Format 0575-6200

Supplemental Identifiers

RxCUI
197593 207634
UNII
O5CB12L4FN

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name proglycem (source: ndc)
Generic Name diazoxide (source: ndc)
Application Number NDA017453 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 50 mg/mL
source: ndc
Packaging
  • 1 BOTTLE, DROPPER in 1 BOX (0575-6200-30) / 30 mL in 1 BOTTLE, DROPPER
source: ndc

Packages (1)

Ingredients (1)

diazoxide (50 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "451aa56d-e2e5-402f-843a-cddb5b3d37dd", "openfda": {"unii": ["O5CB12L4FN"], "rxcui": ["197593", "207634"], "spl_set_id": ["b16c7832-2fd9-49af-b923-1dc0d91fd6e2"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, DROPPER in 1 BOX (0575-6200-30)  / 30 mL in 1 BOTTLE, DROPPER", "package_ndc": "0575-6200-30", "marketing_start_date": "19900930"}], "brand_name": "Proglycem", "product_id": "0575-6200_451aa56d-e2e5-402f-843a-cddb5b3d37dd", "dosage_form": "SUSPENSION", "product_ndc": "0575-6200", "generic_name": "diazoxide", "labeler_name": "Teva Pharmaceuticals USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Proglycem", "active_ingredients": [{"name": "DIAZOXIDE", "strength": "50 mg/mL"}], "application_number": "NDA017453", "marketing_category": "NDA", "marketing_start_date": "19900930", "listing_expiration_date": "20261231"}